Evaluation of Salivary Gal-7, Gal-10 and MMP-9 Levels of Individuals With Different Periodontal Diseases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorIzmir Katip Celebi University

About this trial

The aim of this study is; detection of Galectin-10, Galectin-7, MMP-9 levels in saliva samples of periodontally healthy, gingivitis and periodontitis patients and the possible correlation between these values and clinical parameters of periodontal diseases. Materials and methods: Samples of saliva were obtained from 60 systemically healthy non-smoker individuals with periodontitis (P, n=20), gingivitis(G, n=20) and healthy periodontium (S, n=20). Full-mouth clinical periodontal measurements including probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI) and plaque index (PI) were also recorded. Enzyme-linked immunosorbent assay (ELISA) was used to determine Galectin-10, Galectin-7 and MMP-9 levels in the biological samples.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Systemically healthy (The determination of healthy volunteers will be based on the statements of the patients in the anamnesis. No additional examinations will be made.)

At least twenty permanent teeth in the mouth

Non-smoker

No medication for continuous use

Disqualifiers

Any oral or systemic disease

Regularly using a systemic medication

During pregnancy or lactation

Received periodontal treatment within the last 6 months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Saliva obtaining

    Diagnostic test

    The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Healthy periodontiumExperimental treatment 1 intervention
Group B: GingivitisExperimental treatment 1 intervention
Group C: PeriodontitisExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The total amount of Gal-10 in saliva

The total amount of Galectin-10 in saliva

Time frame
24 hours after taking the clinical measurements at the first visit
2

The total amount of Gal-7 in saliva

The total amount of Galectin-7 in saliva

Time frame
24 hours after taking the clinical measurements at the first visit
3

The total amount of MMP-9 in saliva

The total amount of Matrix metalloproteinase 9 in saliva

Time frame
24 hours after taking the clinical measurements at the first visit

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.